Freidoun Albertioni Selected Research

9-arabinofuranosylguanine

11/2002	Resistance to mitochondrial- and Fas-mediated apoptosis in human leukemic cells with acquired resistance to 9-beta-D-arabinofuranosylguanosine.
5/2002	Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Freidoun Albertioni Research Topics

Disease

11	Leukemia 05/2010 - 01/2002
9	Neoplasms (Cancer) 01/2010 - 01/2002
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2005 - 06/2002
2	T-Cell Leukemia (Leukemia, T Cell) 07/2011 - 04/2009
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2006 - 03/2003
1	Muscular Diseases (Myopathy) 03/2005
1	Lipodystrophy 03/2005
1	Hematologic Neoplasms (Hematological Malignancy) 07/2004
1	Lymphoid Leukemia 03/2003
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2002

Drug/Important Bio-Agent (IBA)

7	Cladribine FDA LinkGeneric 03/2006 - 01/2002
5	NucleosidesIBA 01/2010 - 03/2003
5	Pharmaceutical PreparationsIBA 12/2009 - 01/2002
4	Methotrexate (Mexate)FDA LinkGeneric 04/2009 - 12/2004
3	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 07/2011 - 06/2002
3	NucleotidesIBA 01/2010 - 03/2003
3	Clofarabine (Clolar)FDA Link 12/2009 - 01/2003
3	Folic Acid AntagonistsIBA 04/2009 - 12/2004
3	7-hydroxymethotrexateIBA 04/2009 - 12/2004
3	deoxyguanosine kinaseIBA 03/2006 - 11/2002
2	Thioguanine (Tioguanine)FDA Link 07/2011 - 04/2006
2	Ligases (Synthetase)IBA 04/2009 - 01/2002
2	fludarabineIBA 03/2006 - 01/2003
2	Deoxycytidine KinaseIBA 03/2006 - 11/2002
2	DeoxycytidineIBA 03/2006 - 03/2003
2	EnzymesIBA 03/2005 - 11/2002
2	9-arabinofuranosylguanineIBA 11/2002 - 05/2002
1	Equilibrative-Nucleoside Transporter 2IBA 07/2011
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 07/2011
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2010
1	Antiviral Agents (Antivirals)IBA 01/2010
1	deoxyribonucleoside kinasesIBA 01/2010
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 12/2009
1	DNA (Deoxyribonucleic Acid)IBA 12/2009
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2009
1	Proteins (Proteins, Gene)FDA Link 04/2009
1	Small Interfering RNA (siRNA)IBA 04/2006
1	2-mercaptopurineIBA 04/2006
1	Messenger RNA (mRNA)IBA 03/2006
1	ProdrugsIBA 03/2006
1	Reverse Transcriptase InhibitorsIBA 03/2005
1	2-chloroadenineIBA 07/2004
1	purineIBA 01/2003
1	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 06/2002
1	Azathioprine (Imuran)FDA LinkGeneric 06/2002
1	trioctyl phosphine oxide (TOPO)IBA 01/2002
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2002
1	Purine NucleosidesIBA 01/2002
1	Etoposide (VP 16)FDA LinkGeneric 01/2002
1	Viral DNAIBA 01/2002

Therapy/Procedure

4	Therapeutics 12/2009 - 01/2002
2	Drug Therapy (Chemotherapy) 01/2010 - 01/2002